RecallDepth
Class II Terminated

Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, packaged as a) 100 ml (when mixed) bottle, NDC 67877-544-88; b) 200 ml (when mixed) bottle NDC 67877-544-68, Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA. Distributed by: Ascend Lab,oratories, LLC Parsippany, NJ 07054

Company
Ascend Laboratories, Llc
Recall Initiated
November 23, 2020
Posted
January 13, 2021
Recall Number
D-0185-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
20,232 bottles
Firm Location
Parsippany, NJ, United States

Reason for Recall

Failed Impurity/Degradation Specifications: Unidentified impurities not complying with specifications were observed in various lots of Cephalexin FOS USP 125 mg/5 mL.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot#: a) 19144340, 19144341, Exp AUG 2021; b) 20142226, 20142227, Exp MAY 2022

More recalls by Ascend Laboratories, Llc

View all recalls by this company →

Other recent Class II Drug recalls